Pralsetinib

ATC L01EX23 · 8 markets · 8 records

Pralsetinib 8 markets · 8 records Forms

Filters

MarketUS 1 GB 1 TW 1 HK 1

Strength

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

100 mgcapsuleGavreto also in GB·TW

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

100 mgcapsuleGavreto also in US·TW

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22

100 mgcapsuleGavreto+1普吉華膠囊100毫克 also in US·GB

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Gavreto ×5

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

Side-by-side table

Strength / form / release	US	GB	TW	HK
100 mg capsule	Gavreto	Gavreto	Gavreto 普吉華膠囊100毫克	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Gavreto

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in HK and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en HK que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 HK 有记录（未在本表显示）。另有 1 個規格/劑型僅在 HK 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.